DelveInsight’s Deep Brain Stimulation Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Deep Brain Stimulation Devices Companies market shares, challenges, Deep Brain Stimulation Devices Market Drivers, barriers, trends, and key market Deep Brain Stimulation Devices companies in the market.
To read more about the latest highlights related to the Deep Brain Stimulation Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/report-store/deep-brain-stimulation-devices-market
Key Takeaways from the Deep Brain Stimulation Devices Market Report
- In January 2026, Abbott Laboratories received FDA approval for its Liberta RC™ DBS system — the smallest rechargeable DBS device available, featuring remote programming capabilities and designed specifically for treating Parkinson’s disease and essential tremors.
- In March 2025, Medtronic plc announced FDA approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI), further advancing personalized treatment for neurological conditions like Parkinson’s disease.
- The Deep Brain Stimulation Devices Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2026 to 2034 to reach approximately USD 2.37 billion by 2034.
- The leading Deep Brain Stimulation Devices Companies include Abbott Laboratories, Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics, Renishaw plc, NeuroPace, Inc., NeuroSigma, Inc., Elekta, LivaNova PLC, SceneRay Co., Ltd., Synapse Biomedical, BrainsWay, Magstim, Newronika S.p.A., Brainlab AG, Functional Neuromodulation Ltd., Theranica Bio-Electronics Ltd., Precisis GmbH, Neuros Medical, Magnus Medical, Inc., and others.
- North America is projected to hold the largest share of the Deep Brain Stimulation Devices market in 2023, driven by the growing prevalence of neurological disorders, rising geriatric population, and supportive government initiatives.
Deep Brain Stimulation Devices Market Dynamics
The deep brain stimulation (DBS) devices market is experiencing significant growth owing to the increasing prevalence of neurological disorders such as Parkinson’s disease and epilepsy. According to the Parkinson’s Foundation (2022), around 90,000 individuals are diagnosed with Parkinson’s disease annually in the United States, with the number of people affected projected to reach 1.2 million by 2034. The World Health Organization (WHO) reported that approximately 50 million people worldwide were affected by epilepsy in 2023, with around 5 million new cases diagnosed annually, making it the most common neurological disorder globally. The expanding elderly population, which is at a higher risk of developing such conditions, along with growing R&D investments and continuous technological innovations in DBS products, are driving market growth throughout the forecast period from 2026 to 2034.
Deep Brain Stimulation Devices Market Segmentation Analysis
Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), Battery Type (Rechargeable and Non-Rechargeable), Application (Parkinson’s Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Get a sneak peek at the Deep Brain Stimulation Devices Market Dynamics @ Deep Brain Stimulation Devices Market Dynamics Analysis
Deep Brain Stimulation Devices Companies
Abbott Laboratories, Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics, Renishaw plc, NeuroPace, Inc., NeuroSigma, Inc., Elekta, LivaNova PLC, SceneRay Co., Ltd., Synapse Biomedical, BrainsWay, Magstim, Newronika S.p.A., Brainlab AG, Functional Neuromodulation, Ltd., Theranica Bio-Electronics Ltd., Precisis GmbH, Neuros Medical, Magnus Medical, Inc., and others.
Deep Brain Stimulation Devices Market Drivers
The demand for deep brain stimulation (DBS) devices is being driven by several key factors, including the rising prevalence of neurological disorders such as Parkinson’s disease, epilepsy, and dystonia, primarily due to a growing geriatric population that is more susceptible to neurodegenerative conditions. Increasing focus on R&D activities, supportive government initiatives focused on brain health, and ongoing technological advancements — including rechargeable neurostimulators, MRI-compatible systems, AI-enabled programming, and minimally invasive surgical techniques — are creating a supportive environment for sustained market growth. These trends are expected to position the deep brain stimulation devices market for robust and steady expansion from 2026 to 2034.
Which MedTech key players in the Deep Brain Stimulation Devices Market are set to emerge as the trendsetter? Explore @ Deep Brain Stimulation Devices Companies
Scope of the Deep Brain Stimulation Devices Market Report
- Coverage: Global
- Study Period: 2023 to 2034
- Forecast Period: 2026 to 2034
- Deep Brain Stimulation Devices Companies: Abbott Laboratories, Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics, Renishaw plc, NeuroPace, Inc., NeuroSigma, Inc., Elekta, LivaNova PLC, SceneRay Co., Ltd., Synapse Biomedical, BrainsWay, Magstim, Newronika S.p.A., Brainlab AG, Functional Neuromodulation, Ltd., Theranica Bio-Electronics Ltd., Precisis GmbH, Neuros Medical, Magnus Medical, Inc., and others.
Interested in knowing the Deep Brain Stimulation Devices Market by 2034? Click to get a snapshot of the Deep Brain Stimulation Devices Market Trends
Table of Contents
- Deep Brain Stimulation Devices Market Report Introduction
- Deep Brain Stimulation Devices Market Executive Summary
- Competitive Landscape
- Regulatory Analysis
- Deep Brain Stimulation Devices Market Key Factors Analysis
- Deep Brain Stimulation Devices Market Porter’s Five Forces Analysis
- Deep Brain Stimulation Devices Market Assessment
- Deep Brain Stimulation Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
